EN |
FR
0
Skip to Content
Home
About Us
Our Team
Portfolio
News
Contact Us
Open Menu
Close Menu
Home
About Us
Our Team
Portfolio
News
Contact Us
Open Menu
Close Menu
Home
About Us
Our Team
Portfolio
News
Contact Us
AstraZeneca Closes Acquisition of Amolyt Pharma
2023
2024
Jul 15
Written By
Guest User
Guest User
Previous
Previous
Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101
Next
Next
Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca